Stéphane faced skepticism from his team as he pushed for a shift in focus towards the emerging pandemic. By leveraging insights from his network, he successfully rallied his team around the urgency of the situation. Emphasizing the unique capabilities of their mRNA technology, he highlighted the potential for rapid vaccine development, showcasing a culture that thrives on innovation and resilience in the face of challenges.
